Rezultati - Jason Gotlib

Refine Results
  1. 1
    Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation

    Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation od Jason Gotlib

    Izdano 2005
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    How I treat atypical chronic myeloid leukemia

    How I treat atypical chronic myeloid leukemia od Jason Gotlib

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    World Health Organization‐defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management od Jason Gotlib

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    World Health Organization‐defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management od Jason Gotlib

    Izdano 2017
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management od Jason Gotlib

    Izdano 2015
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    World Health Organization‐defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management od Jason Gotlib

    Izdano 2011
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Myeloid neoplasms with eosinophilia

    Myeloid neoplasms with eosinophilia od Andreas Reiter, Jason Gotlib

    Izdano 2016
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management od William Shomali, Jason Gotlib

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management

    World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management od William Shomali, Jason Gotlib

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management

    World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management od William Shomali, Jason Gotlib

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update

    Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update od Ayalew Tefferi, Jason Gotlib, Animesh Pardanani

    Izdano 2010
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

    New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis od Andreas Reiter, Tracy I. George, Jason Gotlib

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment

    The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment od Jason Gotlib, Julia E. Maxson, Tracy I. George, Jeffrey W. Tyner

    Izdano 2013
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management

    The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management od Jason Gotlib, Jan Cools, James Malone, Stanley L. Schrier, D. Gary Gilliland, Steven Coutré

    Izdano 2003
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations

    Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations od Robert S. Ohgami, Lisa Ma, Jason D. Merker, Jason Gotlib, Iris Schrijver, James L. Zehnder, Daniel A. Arber

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in <i>Caenorhabditis elegans</i> and <i>Homo sapiens</i>

    Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in <i>Caenorhabditis elegans</i> and <i>Homo sapiens</i> od Massa J. Shoura, Idan Gabdank, Loren Hansen, Jason D. Merker, Jason Gotlib, Stephen D. Levene, Andrew Fire

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    The serum tryptase test: an emerging robust biomarker in clinical hematology

    The serum tryptase test: an emerging robust biomarker in clinical hematology od Peter Valent, Wolfgang R. Sperr, Karl Sotlar, Andreas Reiter, Cem Akin, Jason Gotlib, Hans-Peter Horny, Michel Arock

    Izdano 2014
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Treatment advances have not improved the early death rate in acute promyelocytic leukemia

    Treatment advances have not improved the early death rate in acute promyelocytic leukemia od James Scott McClellan, Holbrook E. Kohrt, Steven Coutré, Jason Gotlib, Ravindra Majeti, Ash A. Alizadeh, Bruno C. Medeiros

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.

    Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. od William Wallace, Stephen T. Ahlers, Jason Gotlib, Valentin Bragin, J. Sugár, R Gluck, Paul Shea, Keith L. Davis, Vahram Haroutunian

    Izdano 1993
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I

    Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I od Ruben A. Mesa, Srđan Verstovšek, Vikas Gupta, John Mascarenhas, Ehab Atallah, Timothy C. Burn, William Sun, Victor Sandor, Jason Gotlib

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: